International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic-Reference-Cited by-同舟云学术

International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic

Published:2022-12 Issue:12 Volume:23 Page:e544-e551
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lee Victor Ho-Fun,Adham Marlinda,Ben Kridis Wala,Bossi Paolo,Chen Ming-Yuan,Chitapanarux Imjai,Gregoire Vincent,Hao Sheng Po,Ho Cheryl,Ho Gwo Fuang,Kannarunimit Danita,Kwong Dora Lai-Wan,Lam Ka-On,Lam Wai Kei Jacky,Le Quynh-Thu,Lee Anne Wing-Mui,Lee Nancy Y,Leung To-Wai,Licitra Lisa,Lim Darren Wan-Teck,Lin Jin-Ching,Loh Kwok Seng,Lou Pei-Jen,Machiels Jean-Pascal,Mai Hai-Qiang,Mesía Ricard,Ng Wai-Tong,Ngan Roger Kai-Cheong,Tay Joshua K,Tsang Raymond King-Yin,Tong Chi-Chung,Wang Hung-Ming,Wee Joseph T

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. SARS-CoV-2 omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses;Dejnirattisai;Cell,2022

2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

4. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

5. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study;Lopez Bernal;BMJ,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders;Cancers;2024-01-16

2. Efficacy of induction chemotherapy in lymph node-positive stage III nasopharyngeal carcinoma and identification of beneficiaries based on clinical features: A propensity score matching analysis;Oral Oncology;2023-11

3. Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study;Blood Advances;2023-10-16

4. The genetic associations of COVID-19 on genitourinary symptoms;Frontiers in Immunology;2023-06-21

5. Clinical relevance of plasma EBV DNA as a biomarker for nasopharyngeal carcinoma in non-endemic areas: A multicenter study in southwestern China;Clinica Chimica Acta;2023-02